KINIKSA PHARMACEUTICALS INTL

Ticker: KNSA CUSIP: G52694109 Class: Common Stock

Lion Point Capital, LP's Holding History (CIK: 0001643354)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025

Shares 23,400 Value ($000) $909 Avg Close $32.49 Range $26.27 - $39.00

Q2 2025

Shares 45,900 Value ($000) $1,270 Avg Close $25.46 Range $18.25 - $30.69

Q1 2025

Shares 45,900 Value ($000) $1,019 Avg Close $20.58 Range $17.82 - $24.31

Q4 2024

Shares 45,900 Value ($000) $908 Avg Close $22.82 Range $19.47 - $28.15

Q3 2024

Shares 61,400 Value ($000) $1,534 Avg Close $24.36 Range $17.38 - $27.92

Q2 2024

Shares 104,691 Value ($000) $1,955 Avg Close $18.73 Range $16.56 - $20.52

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2025	23,400	$909	$32.49	$26.27 - $39.00
Q2 2025	45,900	$1,270	$25.46	$18.25 - $30.69
Q1 2025	45,900	$1,019	$20.58	$17.82 - $24.31
Q4 2024	45,900	$908	$22.82	$19.47 - $28.15
Q3 2024	61,400	$1,534	$24.36	$17.38 - $27.92
Q2 2024	104,691	$1,955	$18.73	$16.56 - $20.52